Tag: clinical vendor oversight

Vendor Risk Categorization Frameworks

October 8, 2025

Vendor Risk Categorization Frameworks Building Effective Vendor Risk Categorization Frameworks for Clinical Trials Introduction: Why Vendor Risk Categorization Matters Clinical trials rely on multiple outsourced vendors—CROs, laboratories, IT providers, and logistics partners—each carrying unique risks. To comply with ICH-GCP E6(R2), FDA, and EMA requirements, sponsors must apply risk-based oversight. Vendor risk categorization frameworks provide structured…

Due Diligence and Risk Assessment, Outsourcing and Vendor Management

Combining Financial and Technical Due Diligence

October 5, 2025

digi

Combining Financial and Technical Due Diligence Integrating Financial and Technical Due Diligence for Vendor Qualification Introduction: Why Financial and Technical Evaluations Must Be Linked In clinical trial outsourcing, vendor evaluation often focuses either on technical expertise or financial viability. However, regulators and industry best practices require sponsors to consider both aspects together. A vendor may…

Due Diligence and Risk Assessment, Outsourcing and Vendor Management

Red Flags in Vendor Risk Assessment

October 4, 2025

digi

Red Flags in Vendor Risk Assessment Identifying Red Flags in Vendor Risk Assessments for Clinical Trials Introduction: Why Detecting Red Flags Matters Vendor risk assessments are critical to ensuring compliance, data integrity, and patient safety in clinical trials. Sponsors rely on CROs, central labs, IT vendors, and other partners, but not all vendors are equally…

Due Diligence and Risk Assessment, Outsourcing and Vendor Management